
Denis Dufrane
Dufrane received his medical degree and doctorate in biomedical sciences from UCLouvain and was previously head of the Musculoskeletal Tissue Bank and Tissue/Cells Therapy Centre at Saint-Luc University Hospital in Brussels. He co-founded Novadip in 2013 and joined full-time in 2015. The company's 3M3 tissue regeneration platform uses adipose-derived stem cells, and has raised EUR 88 million in total funding including EUR 40 million in a 2022 round and a subsequent EIB venture debt tranche under InvestEU.
Career
Roles
TexereCo-FounderNov 2016 – Present
- Grand Hôpital de CharleroiMedical officer of the Cell and Tissue Therapy UnitNov 2015 – Present
- Theracell ConsultingFounderAug 2015 – Present
- NOVADIP Biosciences S.A.CEO & Scientific FounderMay 2013 – Present
Université catholique de Louvain#9factoryProfessorOct 2014 – May 2016
- Cliniques universitaires Saint-Luc#619factoryHead of Skin BankOct 2013 – Aug 2015
- Cliniques universitaires Saint-Luc#619factoryHead of Tissue and Cells Therapy Center2012 – Aug 2015
- Cliniques universitaires Saint-Luc#619factoryHead of Endocrine Cell Therapy Unit and Muskulo-Skeletal Tissue Bank2009 – Aug 2015
Université catholique de Louvain#9factoryTeaching Assistant2004 – 2007
- Cliniques universitaires Saint-Luc#619factoryMedical director of Beta Cell Laboratory2002 – 2009
Education
INSEAD#15schoolCertificate, Financial Analysis for Non-Financial ManagersOct 2021 - Dec 2021
Université catholique de Louvain#4schoolDoctor of Philosophy (PhD), Cell transplantation in Diabetes2002 - 2006
Université catholique de Louvain#4schoolMaster's degree, Cell/Cellular and Molecular Biology2000 - 2001
Université catholique de Louvain#4schoolDoctor of Medicine (MD)1993 - 2000
From public career histories · 14 entries